Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
TdBTS
Predictors of Cardiac Troponin Release After Tour de Borobudur 2017
1 other identifier
observational
94
1 country
1
Brief Summary
Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2017
CompletedFirst Posted
Study publicly available on registry
October 16, 2017
CompletedStudy Start
First participant enrolled
October 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2018
CompletedResults Posted
Study results publicly available
October 2, 2019
CompletedOctober 10, 2019
October 1, 2019
14 days
October 2, 2017
July 30, 2018
October 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiac Troponin I (cTnI)
specific protein to determine cardiac injury
immediate after TdB 2017 cycling touring within less than 5 min
Malondialdehyde (MDA)
oxydative stress marker
immediate after TdB 2017 cycling touring within less than 5 min
Secondary Outcomes (2)
High Sensitivity C Reactive Protein (Hs-CRP)
immediate after TdB 2017 cycling touring within less than 5 min
Number of Participants With Pathological ECG Appearance
immediate after TdB 2017 cycling touring within less than 5 min
Study Arms (3)
Group 140kms cycling
Participants of Tour de Borobudur 2017 140 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Group 100kms cycling
Participants of Tour de Borobudur 2017 100 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Group 240kms cycling
Participants of North Coast 2017 240 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Interventions
Main exposure is long distance cycling touring (TdB/NC) consists of three groups; 140kms, 100kms, and 240kms (investigator did not give any treatment/intervention, just observed the cycling touring event)
Eligibility Criteria
participants of Tour de Borobudur Indonesia 2017
You may qualify if:
- minimum sample size of 80 men, non athlete, participants of TdB
- Classified into two groups: 160kms cycling and 100kms cycling participation
- years old
- voluntary participate in the research
- eligible in pre participatory physical examination and ECG test by doctor have no history of previous acute coronary syndrome (ACS)
You may not qualify if:
- stop cycling before finish line due to mechanical or bicycle related errors
- (subjects who stop cycling due to any physical symptoms and health related problem included in analysis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Negeri Semarang
Semarang, Central Java, 50229, Indonesia
Related Publications (16)
Serrano-Ostariz E, Terreros-Blanco JL, Legaz-Arrese A, George K, Shave R, Bocos-Terraz P, Izquierdo-Alvarez S, Bancalero JL, Echavarri JM, Quilez J, Aragones MT, Carranza-Garcia LE. The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand J Med Sci Sports. 2011 Apr;21(2):244-9. doi: 10.1111/j.1600-0838.2009.01042.x.
PMID: 19919634BACKGROUNDGrande G, Romppel M, Glaesmer H, Petrowski K, Herrmann-Lingen C. The type-D scale (DS14) - Norms and prevalence of type-D personality in a population-based representative sample in Germany. Pers Individ Dif [Internet]. 2010;48(8):935-9. Available from: http://dx.doi.org/10.1016/j.paid.2010.02.026
BACKGROUNDLee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: 10.1186/1479-5868-8-115.
PMID: 22018588BACKGROUNDKleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research; Principles and quantitative methods. New York: John Wiley and Son Inc; 1982. 1-527 p.
BACKGROUNDBahrudin U, Morikawa K, Takeuchi A, Kurata Y, Miake J, Mizuta E, Adachi K, Higaki K, Yamamoto Y, Shirayoshi Y, Yoshida A, Kato M, Yamamoto K, Nanba E, Morisaki H, Morisaki T, Matsuoka S, Ninomiya H, Hisatome I. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction. J Mol Biol. 2011 Nov 4;413(4):857-78. doi: 10.1016/j.jmb.2011.09.006. Epub 2011 Sep 12.
PMID: 21939669BACKGROUNDBahrudin U, Morisaki H, Morisaki T, Ninomiya H, Higaki K, Nanba E, Igawa O, Takashima S, Mizuta E, Miake J, Yamamoto Y, Shirayoshi Y, Kitakaze M, Carrier L, Hisatome I. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol. 2008 Dec 26;384(4):896-907. doi: 10.1016/j.jmb.2008.09.070. Epub 2008 Oct 7.
PMID: 18929575BACKGROUNDPurwowiyoto SL, Aryadi A, Suryaatmadja B, Ruray D, Purwowiyoto BS, Siswanto BB. Positive correlation between ECG dispersion mapping (heartvueTM) with T2DM patients. Glob Heart [Internet]. 2014;9(1):e243. Available from: http://linkinghub.elsevier.com/retrieve/pii/S221181601402119X
BACKGROUNDde Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007 Apr;28(7):850-6. doi: 10.1093/eurheartj/ehm026. Epub 2007 Apr 2.
PMID: 17403720BACKGROUNDShave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, Gaze D, Collinson PO. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc. 2007 Dec;39(12):2099-106. doi: 10.1249/mss.0b013e318153ff78.
PMID: 18046180BACKGROUNDMorrow DA. Troponins in patients with acute coronary syndromes: biologic, diagnostic, and therapeutic implications. Cardiovasc Toxicol. 2001;1(2):105-10. doi: 10.1385/ct:1:2:105.
PMID: 12213981BACKGROUNDJassal DS, Moffat D, Krahn J, Ahmadie R, Fang T, Eschun G, Sharma S. Cardiac injury markers in non-elite marathon runners. Int J Sports Med. 2009 Feb;30(2):75-9. doi: 10.1055/s-0028-1104572. Epub 2009 Jan 28.
PMID: 19177312BACKGROUNDRodondi N, Marques-Vidal P, Butler J, Sutton-Tyrrell K, Cornuz J, Satterfield S, Harris T, Bauer DC, Ferrucci L, Vittinghoff E, Newman AB; Health, Aging, and Body Composition Study. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am J Epidemiol. 2010 Mar 1;171(5):540-9. doi: 10.1093/aje/kwp428. Epub 2010 Jan 28.
PMID: 20110287BACKGROUNDEijsvogels TM, Hoogerwerf MD, Maessen MF, Seeger JP, George KP, Hopman MT, Thijssen DH. Predictors of cardiac troponin release after a marathon. J Sci Med Sport. 2015 Jan;18(1):88-92. doi: 10.1016/j.jsams.2013.12.002. Epub 2014 Jan 2.
PMID: 24440407BACKGROUNDSerrano-Ostariz E, Legaz-Arrese A, Terreros-Blanco JL, Lopez-Ramon M, Cremades-Arroyos D, Carranza-Garcia LE, Izquierdo-Alvarez S, Bocos-Terraz P. Cardiac biomarkers and exercise duration and intensity during a cycle-touring event. Clin J Sport Med. 2009 Jul;19(4):293-9. doi: 10.1097/JSM.0b013e3181ab3c9d.
PMID: 19638823BACKGROUNDEijsvogels T, George K, Shave R, Gaze D, Levine BD, Hopman MT, Thijssen DH. Effect of prolonged walking on cardiac troponin levels. Am J Cardiol. 2010 Jan 15;105(2):267-72. doi: 10.1016/j.amjcard.2009.08.679.
PMID: 20102930BACKGROUNDNeumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagl H. Effect of the "Race Across The Alps" in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol. 2002 Feb 15;89(4):484-6. doi: 10.1016/s0002-9149(01)02280-9. No abstract available.
PMID: 11835940BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Mahalul Azam
- Organization
- Universitas Negeri Semarang
Study Officials
- PRINCIPAL INVESTIGATOR
Mahalul Azam, Dr
Universitas Negeri Semarang
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2017
First Posted
October 16, 2017
Study Start
October 28, 2017
Primary Completion
November 11, 2017
Study Completion
May 5, 2018
Last Updated
October 10, 2019
Results First Posted
October 2, 2019
Record last verified: 2019-10